In patients with stable persistent asthma, can lower doses of inhaled corticosteroid medication control symptoms and maintain optimal pulmonary function as well as high doses?
Jackson
E A
EA
University of Connecticut, Saint Francis Hospital and Medical Center, Hartford, USA. ejackson2@stfranciscare.org
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D019819:Budesonide / Q000008:administration & dosage* / Q000494:pharmacology; D002908:Chronic Disease; D004311:Double-Blind Method; D006801:Humans; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D015203:Reproducibility of Results; D012129:Respiratory Function Tests; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D019819:Budesonide